Search details
1.
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.
N Engl J Med
; 375(11): 1019-32, 2016 Sep 15.
Article
in English
| MEDLINE | ID: mdl-27626517
2.
Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trials.
Pain
; 164(4): 741-748, 2023 04 01.
Article
in English
| MEDLINE | ID: mdl-36066965
3.
Towards a Greener Approach for Biomass Valorization: Integration of Supercritical Fluid and Deep Eutectic Solvents.
Antibiotics (Basel)
; 12(6)2023 Jun 08.
Article
in English
| MEDLINE | ID: mdl-37370350
4.
Comparison of Different Green Extraction Techniques Used for the Extraction of Targeted Flavonoids from Edible Feijoa (Acca sellowiana (O.Berg) Burret) Flowers.
Plants (Basel)
; 12(7)2023 Mar 27.
Article
in English
| MEDLINE | ID: mdl-37050087
5.
Optimization of Deep Eutectic Solvent Extraction of Phenolic Acids and Tannins from Alchemilla vulgaris L.
Plants (Basel)
; 11(4)2022 Feb 09.
Article
in English
| MEDLINE | ID: mdl-35214807
6.
Terpenes and Cannabinoids in Supercritical CO2 Extracts of Industrial Hemp Inflorescences: Optimization of Extraction, Antiradical and Antibacterial Activity.
Pharmaceuticals (Basel)
; 15(9)2022 Sep 07.
Article
in English
| MEDLINE | ID: mdl-36145338
7.
Determination of Suitable Macroporous Resins and Desorbents for Carnosol and Carnosic Acid from Deep Eutectic Solvent Sage (Salvia officinalis) Extract with Assessment of Antiradical and Antibacterial Activity.
Antioxidants (Basel)
; 10(4)2021 Apr 02.
Article
in English
| MEDLINE | ID: mdl-33918515
8.
Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study.
Hum Vaccin Immunother
; 14(8): 1977-1986, 2018.
Article
in English
| MEDLINE | ID: mdl-29630439
9.
Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials.
Vaccine
; 36(12): 1537-1541, 2018 03 14.
Article
in English
| MEDLINE | ID: mdl-29463421
10.
Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial.
Hum Vaccin Immunother
; 13(5): 1051-1058, 2017 05 04.
Article
in English
| MEDLINE | ID: mdl-28068212
11.
Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and inactivated poliovirus booster vaccine (dTpa-IPV) in healthy adults.
Vaccine
; 33(22): 2594-601, 2015 May 21.
Article
in English
| MEDLINE | ID: mdl-25882172
12.
Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
Vaccine
; 33(23): 2727-33, 2015 May 28.
Article
in English
| MEDLINE | ID: mdl-24962750
13.
Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines.
Influenza Other Respir Viruses
; 8(4): 452-62, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24702710
14.
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial.
Lancet Infect Dis
; 13(6): 485-96, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-23518156
Results
1 -
14
de 14
1
Next >
>>